Virax Biolabs Group Limited (VRAX)

NASDAQ: VRAX · IEX Real-Time Price · USD

0.644

-0.029 (-4.29%)

At close: Apr 19, 2024, 2:23 PM

0.710

+0.066 (10.25%)

After-hours: Apr 19, 2024, 5:14 PM EDT

Virax Biolabs Group Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year	Current	2022
Market Capitalization	2	8
Enterprise Value	-3	-1
PE Ratio	-0.73	-1.49
PS Ratio	21.19	947.36
PB Ratio	0.27	0.89
P/FCF Ratio	-0.84	-1.86
P/OCF Ratio	-0.95	-1.94
EV/Sales Ratio	1.60	-128.02
EV/EBITDA Ratio	-	0.20
EV/EBIT Ratio	-0.02	0.20
EV/FCF Ratio	-0.02	0.25
Debt / Equity Ratio	0.03	0.02
Debt / EBITDA Ratio	-	-0.03
Debt / FCF Ratio	-0.03	-0.03
Quick Ratio	6.49	10.30
Current Ratio	7.59	10.61
Asset Turnover	0.01	0.00
Interest Coverage	-432.43	-351.82
Return on Equity (ROE)	-129.10%	-133.90%
Return on Assets (ROA)	-112.40%	-110.70%
Return on Capital (ROIC)	-107.42%	-61.82%
Earnings Yield	-412.11%	-67.29%
FCF Yield	-360.06%	-53.74%
Buyback Yield / Dilution	-664.03%	-11.15%
Total Shareholder Return	-664.03%	-11.15%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).